Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Ribupatide

A Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

Fujian Shengdi Pharmaceutical Co · Phase 2 · Completed · Enrollment 249

NCT05881837

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Treatment group An/rn/rn/rn/r
Treatment group Bn/rn/rn/rn/r
Treatment group Cn/rn/rn/rn/r
Treatment group Dn/rn/rn/rn/r
Treatment group En/rn/rn/rn/r
Treatment group Fn/rn/rn/rn/r
Treatment group Gn/rn/rn/rn/r
Treatment group Hn/rn/rn/rn/r

Not shown

  • Treatment group A: endpoint not reported
  • Treatment group B: endpoint not reported
  • Treatment group C: endpoint not reported
  • Treatment group D: endpoint not reported
  • Treatment group E: endpoint not reported
  • Treatment group F: endpoint not reported
  • Treatment group G: endpoint not reported
  • Treatment group H: endpoint not reported